DSCAM-AS1 and breast carcinoma: Furthermore, in breast cancer cells, transcription of DSCAM-AS1 was shown to be mainly activated by FOXA1 and was in turn able to affect expression of its regulators ERα and FOXA1 via interaction with YBX1, forming a positive feedback loop leading to breast cancer progression [17].